Xiaoling Zhou
Head of AP BD at Crystal Pharmatech. Director of Business Development at Crystal Pharmatech- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Crystal Pharmatech
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Head of AP BD at Crystal Pharmatech. Director of Business Development
-
Jul 2023 - Present
Business Development, Client collaboration for Solid State Research, Pre-formulation and Formulation. “First Time Right with Line of Sight”: Direct Route to FIH.Solid State Research- Solid State Research and Developability Assessment- API Form Selection (Polymorph/Salt/Cocrystal)- Crystallization Development- Single Crystal and Structure Determination…Pre-formulation Study- Formulation development for PK/PD and GLP Tox studies- Solution/Suspension Formulations- ASD Preparation and Evaluation- Nano Milling…Formulation and Manufacture, Clinical Sample Supply- Formulation risk assessment- Formulation & Analytical Development- GMP Manufacturing & Clinical Supply- Regulatory Support and Other Services… Show less
-
-
Associate BD Director
-
Apr 2022 - Jul 2023
Business development activities, client collaboration of Asia Pacific and USSolid state research, per-formulation study...
-
-
Senior BD Manager
-
Apr 2019 - Mar 2022
Business development activities, client collaboration of Asia Pacific and US
-
-
BD Manager
-
Oct 2016 - Mar 2019
Business development, client collaboration
-
-
Business Development Specilist
-
Dec 2014 - Sep 2016
Business development activities, client collaboration
-
-
Research Scientist/Project Leader/Team Leader
-
May 2012 - Dec 2014
Solid-State Research- Polymorph Screening and Evaluation- Salt/Cocrystal Screening and EvaluationPreformulation Studies- Solution/Suspension Formulations- ASD Preparation and Evaluation
-
-
Education
-
Southeast University
Analytical Chemistry